Stryker Corp
SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3020% below fair value
$306.81+14.95 (+5.12%)
Close on Nov 2, 2026Market cap $117.68BP/E 32.7Yield –
Stryker MedSurg & Neurotechnology — U.S. Net Sales by Year
MedSurg & Neurotechnology — U.S. Net Sales ($M) ($M)
Stryker MedSurg & Neurotechnology — U.S. Net Sales: $10,815M in FY2025, up 17.9% from a year earlier.
Latest, FY2025
10,815
Period ended Dec 31, 2025
Change on a year earlier
+17.9%
9,175 in FY2024
History
7 years
Since FY2019
Sources
5
Documents cited below
Where the FY2025 figure comes from
Reported in Stryker Form 8-K, Form 10-Q Note 15 XBRL & Change-in-Presentation Recast Schedules.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | MedSurg & Neurotechnology — U.S. Net Sales ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 10,815 | +17.9% | 0000310764-26-000041|syk-20260626_d2.htm ↗ |
| FY2024 | Dec 31, 2024 | 9,175 | +13.1% | 0000310764-26-000041|syk-20260626_d2.htm ↗ |
| FY2023 | Dec 31, 2023 | 8,112 | -1.6% | 0000310764-26-000041|syk-20260626_d2.htm ↗ |
| FY2022 | Dec 31, 2022 | 8,248 | +17.4% | Stryker Form 10-K — FY2024 (filed 2025-02-12) ↗ |
| FY2021 | Dec 31, 2021 | 7,026 | +13.0% | Stryker Form 10-K — FY2023 (filed 2024-02-14) ↗ |
| FY2020 | Dec 31, 2020 | 6,218 | -3.9% | Stryker Form 10-K — FY2022 (filed 2023-02-10) ↗ |
| FY2019 | Dec 31, 2019 | 6,470 | – | Stryker Form 10-K — FY2021 (filed 2022-02-11) ↗ |
Cite this data
StockData. (2026). Stryker MedSurg & Neurotechnology — U.S. Net Sales ($M), annual FY2019–FY2025 [Data set]. Compiled from Stryker SEC filings and investor materials. https://stockdatahq.com/stocks/syk/kpis/ms-tot-us-rev
See every metric in the Stryker KPI table. Data updated Nov 2, 2026.